tiprankstipranks
PYC Therapeutics Limited (AU:PYC)
ASX:PYC
Australian Market

PYC Therapeutics Limited (PYC) Financial Statements

5 Followers

PYC Therapeutics Limited Financial Overview

PYC Therapeutics Limited's market cap is currently ―. The company's EPS TTM is AU$-0.006; its P/E ratio is -22.50; PYC Therapeutics Limited is scheduled to report earnings on August 27, 2024, and the estimated EPS forecast is AU
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 29.11MAU$ 51.50MAU$ 25.13MAU$ 6.18MAU$ 3.15M
Total AssetsAU$ 45.35MAU$ 57.94MAU$ 31.55MAU$ 6.70MAU$ 3.42M
Total DebtAU$ 943.77KAU$ 730.35KAU$ 798.14KAU$ 0.00AU$ 0.00
Net DebtAU$ -28.17MAU$ -50.77MAU$ -24.33MAU$ -6.18MAU$ -3.15M
Total LiabilitiesAU$ 5.15MAU$ 4.02MAU$ 1.35MAU$ 401.87KAU$ 1.77M
Stockholders EquityAU$ 39.35MAU$ 52.54MAU$ 27.95MAU$ 6.30MAU$ 1.65M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

PYC Therapeutics Limited Earnings and Revenue History

PYC Therapeutics Limited Debt to Assets

PYC Therapeutics Limited Cash Flow

PYC Therapeutics Limited Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis